You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GSK656

Showing 1 - 25 of 121
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (Placebo ELLIPTA, Nemiralisib ELLIPTA 50 µg, Nemiralisib ELLIPTA 100

Terminated
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Placebo ELLIPTA
  • +7 more
  • Mobile, Alabama
  • +161 more
Jul 13, 2021

Melanoma Trial in Worldwide (Immunotherapeutic GSK2302025A, different formulations)

Completed
Has Results
  • Melanoma
  • Immunotherapeutic GSK2302025A, different formulations
  • Brno, Czechia
  • +36 more
Oct 23, 2020

Melanoma Trial in Worldwide (GSK 2132231A, Placebo)

Terminated
Has Results
  • Melanoma
  • GSK 2132231A
  • Placebo
  • Birmingham, Alabama
  • +256 more
Feb 5, 2021

Pulmonary Tuberculosis Trial (GSK3036656, BTZ-043, Bedaquiline (B))

Not yet recruiting
  • Pulmonary Tuberculosis
  • (no location specified)
Oct 27, 2023

Tuberculosis Trial (GSK3036656, Bedaquiline, Delamanid)

Recruiting
  • Tuberculosis
  • Cape Town, South Africa
    GSK Investigational Site
Jan 24, 2023

Asthma Trial in Worldwide (Mepolizumab 100mg, Placebo)

Completed
Has Results
  • Asthma
  • Mepolizumab 100mg
  • Placebo
  • Long Beach, California
  • +73 more
Jan 23, 2020

Melanoma Trial in Worldwide (Dabrafenib, Trametinib, Placebos)

Active, not recruiting
Has Results
  • Melanoma
  • Birmingham, Alabama
  • +209 more
Nov 14, 2022

Tuberculosis Trial in Cape Town (GSK3036656, RIFAFOUR e-275)

Completed
  • Tuberculosis
  • Cape Town, South Africa
    GSK Investigational Site
Dec 30, 2021

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
Jul 27, 2022

Respiratory Syncytial Virus Infections Trial in Fukuoka (RSV_PreF3 Vaccine (GSK3844766A) adjuvanted with AS01B, Placebo)

Completed
Has Results
  • Respiratory Syncytial Virus Infections
  • RSV_PreF3 Vaccine (GSK3844766A) adjuvanted with AS01B
  • Placebo
  • Fukuoka, Japan
    GSK Investigational Site
Dec 7, 2021

HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)

Active, not recruiting
Has Results
  • HIV Infections
  • DTG 50 mg
  • +2 more
  • Long Beach, California
  • +64 more
Dec 3, 2021

Diabetes Trial in Worldwide (Albiglutide 30 mg, Albiglutide 50 mg, Albiglutide matching )

Completed
Has Results
  • Diabetes Mellitus
  • Albiglutide 30 mg
  • +2 more
  • Birmingham, Alabama
  • +607 more
Feb 11, 2019

Tumors Trial in Worldwide (GSK525762)

Completed
Has Results
  • Neoplasms
  • Little Rock, Arkansas
  • +14 more
Apr 26, 2021

Activated PI3K-delta Syndrome Trial in Cambridge (Nemiralisib)

Completed
Has Results
  • Activated PI3K-delta Syndrome
  • Cambridge, United Kingdom
    GSK Investigational Site
May 26, 2021

HIV Trial in Austin (GSK3640254 Tablet, GSK3640254 Capsule)

Completed
Has Results
  • HIV Infections
  • GSK3640254 Tablet
  • GSK3640254 Capsule
  • Austin, Texas
    GSK Investigational Site
Feb 9, 2021

Influenza Trial in Worldwide (GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations), GSK Biologicals'

Completed
Has Results
  • Influenza
  • GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations)
  • +2 more
  • Kippa Ring, Queensland, Australia
  • +16 more
Feb 3, 2021

Arthritis, Rheumatoid Trial in Worldwide (GSK3196165, MTX, Folic acid)

Completed
Has Results
  • Arthritis, Rheumatoid
  • Plovdiv, Bulgaria
  • +63 more
Dec 10, 2020

Asthma Trial in Germany, United Kingdom (GSK3511294, Placebo, Salbutamol/albuterol)

Completed
Has Results
  • Asthma
  • Hannover, Niedersachsen, Germany
  • +4 more
Feb 5, 2021

Alzheimer's Disease Trial in Worldwide (SB-742457, Donepezil, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Shumen, Bulgaria
  • +71 more
May 31, 2018

Intracranial Meningioma, Recurrent Meningioma, NF2 Gene Mutation Trial in United States (Vismodegib, FAK Inhibitor GSK2256098,

Recruiting
  • Intracranial Meningioma
  • +2 more
  • Birmingham, Alabama
  • +707 more
Sep 25, 2022

Psoriasis Trial in Canada (GSK2982772, Placebo)

Completed
Has Results
  • Psoriasis
  • Markham, Ontario, Canada
  • +3 more
Jun 26, 2020

Urinary Bladder, Overactive Trial in Japan (GSK1358820, Placebo, Antibiotic therapy)

Completed
Has Results
  • Urinary Bladder, Overactive
  • Aichi, Japan
  • +47 more
Nov 13, 2020

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (62.5/25mcg, 62.5mcg, 25mcg)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Tucson, Arizona
  • +164 more
Aug 2, 2018

Asthma Trial in Worldwide (Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler, Placebo inhalation powders via ELLIPTA

Completed
Has Results
  • Asthma
  • Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler
  • +4 more
  • Huntington Beach, California
  • +178 more
Aug 2, 2018

Tumors Trial in United Kingdom, United States (GSK2636771, Enzalutamide)

Completed
Has Results
  • Neoplasms
  • Duarte, California
  • +8 more
Sep 28, 2020